| Product NDC: | 68094-204 |
| Proprietary Name: | Ranitidine Hydrochloride |
| Non Proprietary Name: | Ranitidine Hydrochloride |
| Active Ingredient(s): | 150 mg/10mL & nbsp; Ranitidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68094-204 |
| Labeler Name: | Precision Dose Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078312 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030821 |
| Package NDC: | 68094-204-62 |
| Package Description: | 3 TRAY in 1 CASE (68094-204-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE (68094-204-59) |
| NDC Code | 68094-204-62 |
| Proprietary Name | Ranitidine Hydrochloride |
| Package Description | 3 TRAY in 1 CASE (68094-204-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE (68094-204-59) |
| Product NDC | 68094-204 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine Hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20030821 |
| Marketing Category Name | ANDA |
| Labeler Name | Precision Dose Inc. |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 150 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |